A Szentágothai János Kutatóközpont a PTE korszerű, nemzetközi tudományszervezési és menedzsment normák szerint kialakított új intézménye, amely az élettudományi, élettelen természettudományi, valamint környezettudományi oktatás...
A Szentágothai János Kutatóközpont a PTE korszerű, nemzetközi tudományszervezési és menedzsment normák szerint kialakított új intézménye, amely az élettudományi, élettelen természettudományi, valamint környezettudományi oktatás...
The Translational Neuroscience Research Group was establish by István Hernádi, PhD in 2012 at the University of Pécs. The research group develops preclinical models of neurocognitive disorders in four laboratories:
1. Small animal behavior laboratory: general activity, open field test, elevated plus maze test, forced swim test, food-choice tests, computer controlled operant behavioral chambers, neurotoxic brain lesions, reversible brain inactivation, central/systemic administration of bioactive agents.
2. In vivo cellular laboratory: extracellular unit recording, stereotaxic apparatus, biollogical signal conditioning (amplifiers,filters, ADCs, measurement of voltage and current), constant current ganerators (for microiontophoresis).
3. NHP research laboratory at the Grastyán Endre Translational Research Centre
4. Human psychophysiology laboratory: high performance 32 channel biological amplifier (EEG, EMG, ECG, EOG), computer controlled behavioral apparatus. Current research 1) basic: neurophysiology of face perception; 2) applied: neurocognitve effects of non-ionising environmental electromagnetic fields.
The research group is dedicated to basic and applied research in systems neuroscience. We aim to adopt and further develop in vivo animal and human models of higher order mammalian brain function with special emphasis on searching functional biomarkers of pathological mechanisms related to neurodegenerative brain disorders, esp. Alzheimer's disease, schizophrenia and developmental spectrum disorders. The four laboratories provide a unique repertoire of technical tools for targeting multidisciplinary research within the same research group. Our main objective is to support the need of parallel comprehensive testing of novel drug-candidates against cognitive impairment in in vivo preclinical animal experiments and human studies.
Applied systems neuroscience, drug development and validation
1. Small animal behavior laboratory (SZKK):
Open field test
Tadepalli, SA, Bali, ZK, Bruszt, N, Nagy, LV, Amrein, K, Fazekas, B, Büki, A, Czeiter, E, Hernádi, I (2020). Long-term cognitive impairment without diffuse axonal injury following repetitive mild traumatic brain injury in rats. Behav Brain Res 378:112268. doi:10.1016/j.bbr.2019.112268
Elevated Zero Maze (EOM)
Bali, ZK, Bruszt, N, Kőszegi, Z, Nagy, LV, Atlasz, T, Kovács, P, Csupor, D, Csupor-Löffler, B, Hernádi, I (2022) Aconitum Alkaloid Songorine Exerts Potent Gamma-Aminobutyric Acid-A Receptor Agonist Action In Vivo and Effectively Decreases Anxiety without Adverse Sedative or Psychomotor Effects in the Rat. Pharmaceutics. doi: 10.3390/pharmaceutics14102067
Novel object recognition (NOR) test
Tadepalli, SA, Bali, ZK, Bruszt, N, Nagy, LV, Amrein, K, Fazekas, B, Büki, A, Czeiter, E, Hernádi, I (2020). Long-term cognitive impairment without diffuse axonal injury following repetitive mild traumatic brain injury in rats. Behav Brain Res 378:112268. doi:10.1016/j.bbr.2019.112268
Morris water maze (MWM)
Bruszt, N, Bali, ZK, Tadepalli, SA, Nagy, LV, Hernádi, I (2021) Potentiation of cognitive enhancer effects of Alzheimer’s disease medication memantine by alpha7 nicotinic acetylcholine receptor agonist PHA-543613 in the Morris water maze task. Psychopharmacology. doi: 10.1007/s00213-021-05942-4
Psychomotor vigilance task (PVT)
Bali, ZK, Nagy, LV, Bruszt, N, Bodó, K, Engelmann, P, Hernádi, Z, Göntér, K, Tadepalli, SA, Hernádi, I (2023) Increased brain cytokine level associated impairment of vigilance and memory in aged rats can be alleviated by alpha7 nicotinic acetylcholine receptor agonist treatment. Geroscience: Official Journal Of The American Aging Association (Age). doi: 10.1007/s11357-023-01019-6
Spontaneous alternation test in a T-maze
Bali ZK, Bruszt N, Tadepalli SA, Csurgyók R, Nagy LV, Tompa M, Hernádi I (2019). Cognitive enhancer effects of low memantine doses are facilitated by an alpha7 nicotinic acetylcholine receptor agonist in scopolamine-induced amnesia in rats. Front Pharmacol 10:73. doi: 10.3389/fphar.2019.00073
2. In vivo cellular laboratory (TTK):
3. NHP research laboratory at the Grastyán Endre Translational Research Centre
4. Human psychophysiology laboratory (TTK):